The big problem with OTC tickers - and this one in particular, is that they have ZERO incentive to actually see the stock price rise. Literally, this thing could RS, take a 98% nosedive over two weeks, and NOTHING can happen to management. They don't own shares, they're not compensated if share price increases, they control the board (therego, their contracts, salary, control over expenses, etc).
I really can't imagine their position is that strong - there are clearly numerous manufacturers out there launching glasses free 3-D. If they actually controlled this market, or had their tech in every single player on the market, you would have heard about this company. Even more so, one of the big screen manufacturers would have just bought them out. Instead, they're trading on the OTC and using toxic lenders... that doesn't tie out.